Honesty, Creativity, Integrity

About Us

At a Glance

RK Pharma Inc is a privately held US based company. We focus on the development, manufacturing, and sale of high quality and affordable generic pharmaceutical products worldwide. RK Pharma Inc has uniquely integrated development, regulatory, and manufacturing capabilities, with a focus on products with formulation challenges and first generic opportunities.

Our state-of-the-art facility in Pearl River, New York specializes in managing a seamless process of bulk manufacturing through a multi-format packaging and end-product release testing suited for injectables, sterile ophthalmic and dermal products. Further product development is also being undertaken at our other locations worldwide under the supervision of our experienced formulation, analytical, quality, and regulatory leaders.

Apicore LLC (www.apicore.com), a wholly owned subsidiary of RK Pharma Inc. is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry since 2003. Apicore offers a wide portfolio of services ranging from API’s for the generic industry to custom synthesis for early phase pharmaceutical research and branded products.

Our USFDA approved facilities in India (Visakhapatnam, Andhra Pradesh and Vadodara, Gujarat) are equipped with state-of-the-art analytical and research capabilities.

RK Pharma Inc’s strong pipeline of products are being commercialized in the United States by Archis Pharma LLC (www.archispharma.com) and VGYAAN Pharmaceuticals LLC (www.vgyaan.com) , both wholly owned subsidiaries of RK Pharma Inc.

Our Vision, Mission

RK Pharma Inc was established with the vision of developing and contributing to the health care industry with affordable active pharmaceutical ingredients, generic products and innovative drugs.

Our Mission is to improve quality of life by providing a broad range of high quality, affordable and effective therapeutic products to patients. We achieve this through our excellence in development, manufacturing and commercialization of our drug products.


We embrace a culture that values honesty, creativity, action, integrity in relationships, a passion for success and good stewardship of Company resources. We endeavor to develop, recognize, reward, and retain teammates who deliver results and embody our Vision and Mission. There is nothing more energizing and powerful than being part of an environment that genuinely pursues diversity and inclusion. Our culture is built on a profound respect for and appreciation of our individual backgrounds, experiences, similarities, and differences.

Our Leadership

Our executive team is made up of industry specialists with decades of combined experiences. Our Executive Management Team is dedicated to driving the company’s long-term transformation into a science-centered specialty generics pharmaceutical company. Meet a few members of our Executive team below.


Executive Chairman & Director

20+ years in medicinal/ organic chemistry, clinical and pre-clinical PK/PD and drug metabolism, QC/QA and Regulatory Affairs.

Prior to co-founding RK Pharma & Apicore, worked with Vertex Pharmaceuticals Inc. and Biogen-Idec in USA.

Inventor on several patents and established record of bringing several drugs to the market. Ph.D. in Pharmacy.


President & CEO, Director

Comprehensive experience of over 20 years in New Drug Development and Generic Pharmaceutical Industry

Former President & CEO of a TSX listed public pharmaceutical company- focusing on oncology products

Former President & CEO of a private oncology gene therapy company, VP of Strategic Development of a TSX listed public cardiovascular company. Ph.D. in Pharmacy, and MBA from the Ivey School of Business.



25+ Years of experience in bulk drug industry in various levels in R&D, Product Development, Scale-Up, Commercialization and overall Management of Industry.

Founder Director of Aktinos Pharma

Former Director Vijaisri Organics and prior to that worked in Nicholas Piramal, Vera Laboratories, Jubilant, Ph.D. in Organic Chemistry.


President - Apicore India

Joined Apicore in 2006.

22+ years in the pharmaceutical industry

Prior experience includes Torrent Pharma, Orchid Chemicals & Pharmaceuticals, Navinta Ph.D. in Organic Chemistry.


COO, Director

25+ years of experience across healthcare industry including Payors, Pharma, PBM, and Retail Pharmacy

Former principal at Booz & Company a top management consulting firm with proven track record of solving critical business and operational issues across the healthcare industry

Former VP of corporate strategy and transformational efforts at a large US based health insurance company

MBA from Columbia Business School, NY and Bachelor of Engineering from BITS, Pilani, India


CEO, VGYAAN Pharmaceuticals

25+ years of experience in the pharmaceutical industry with a wide range of companies including start-ups, Fortune 500, private equity owned, and publicly traded companies. A serial entrepreneur, Nailesh is Founder and CEO of VGYAAN Pharmaceuticals. He is also Founder and Managing Director of Proximare, a strategic advisory firm. Prior to Proximare, Nailesh was the founder of BulkDrugs.com. Previously, Nailesh has worked in increasing roles and responsibilities at Sidmak Laboratories, SEPPIC, and Arthur Andersen

Nailesh currently serves as a member of Board of Directors of Azurity Pharmaceuticals, CoreRx Pharma, Spectra Medical Devices, Sonnet BioTherapeutics (NASDAQ: SONN).

Group of Companies

RK Pharma Inc is a group of companies engaged in all phases of the generic pharmaceutical business, with operations in the US and India. Through vertical integration, the RK Pharma group of companies now comprises of India based Apicore Pharmaceuticals Pvt Ltd and Aktinos Pharma; and also a state of the art drug finished dosage form manufacturing facility (former Pfizer manufacturing facility) based in Pearl River , New York, thereby strengthening its manufacturing product capabilities in the US.

In addition, in June 2023, RK Pharma Inc. acquired New Jersey headquartered VGYAAN Pharmaceuticals LLC which added to RK Pharma Inc.’s product portfolio as well as front-end capabilities. Addition of VGYAAN Pharmaceuticals to RK Pharma group of companies adds to our other group company Archis Pharma LLC, the sales and marketing arm, commercializes both the RK Pharma group’s and in-licensed partner products.